emeritus
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
big bids fishing for paper last couple of hours to close- can oui see some thing coming?
LOlolololololololol #busted
There is definitely the scent of an institutional arrogance that just putting out a rando PR is supposed to incite furor and excitement of look look look what we just done.
A successful small cap deal needs as much thought time and preparation in their conversation with the market as does the actual operation of the company.
You’d think the painful lessons of getting the absolute lowest price point on their raise. The doldrums on the boards. The low volume. The dumping after news would finally sink in... that hey? Maybe we aren’t doing this right? And bring in the people who know what their doing and let them loose. But who knows. Maybe ego, pride, arrogance fear and insecurity are owning the process.
Better planning and taking an institutional u-turn on a top down comprehensive understanding that integrating an active ongoing market awareness campaign that operates in clear communication with the logistics side to bear leverage on every opportunity to truly engage shareholder value.
Ie. Protect the float, support the price and actually narrate reality with a huge serving spoon of new adventures and revenue potentials to continue on a daily basis to make certain that you are getting the TOTAL narrative in front of as prospective new shareholders. Fundamentally there is too much assumption- imho- by leadership that the audience is clued in. And all they have to do is put out a rando presser and it’s all going to blow up on massive volume everyday from now till eternity. “They’ll finally get it” syndrome. but that’s not how it is...
The best analogy I can point to is the video on YouTube of a world famous violinist. Who had a show booked at the Lincoln Center in Washington DC. Sold out show. Months in advance. Tickets cost $500-5000 a piece. The artist fee was like $750,000 for the evenings 90 minute performance.
Well the afternoon of the performance the artist decides to take his $2,000,000 Stradivarius Violin and himself down into the concourse of the metro in Washington. Puts a hat on the floor and proceeds to perform the same set planned for later that evening.
In 45 minutes he earned like 32$ - twenty of it was from someone who recognized him. The rest was in spare change and crumpled singles from the over 20,000 people who streamed past him at rush hour in DC - after that he packed up and went to the Linc and wowed the house to thundering standing ovations, write ups in major global newspapers and websites. Why I bet even his mom was proud.
The point is. Same guy. Same violin. Same talent. In one instance huge money global accolades and adoration from some of the most influential people on Earth. In the other instance: just another asshole playing for scraps. It’s all about context.
The Lincoln show would have been heavily promoted on NPR, Television appearances, commercials, web ads and in the newspaper and on radio shows, podcasts, feature articles, live interviews done weeks and months in advance.
Posters, videos, photos, sneak peeks, book stores, music stores luxury car dealers - wherever a customer for a ticket to that show in the DC Virginia Maryland Delaware lived, played or worked there was an attempt to inform them that they could buy a ticket.
On the other hand- it was just some guy fiddlin' in a subway concourse. A world class talent, on a 2 million dollar violin. That nobody noticed.
$evio on track for 18 labs by year end 2018 and we have some exciting announcements to make in the next 30-60 days. In the massive California cannabis testing market, the company is also moving forward with the build-out of a new lab in Costa Mesa, CA as well as finalizing discussions for several regional service centers.
$EVIO is evaluating lab opportunities in Maryland, Pennsylvania, New York, Michigan and Canada.
ISO17025 is the highest recognized quality standard in the world for calibration and testing laboratories. Meeting this standard requires the consistent production of precise and accurate tests and the implementation of a rigorous quality management system.
http://markets.businessinsider.com/news/stocks/evio-inc-update-letter-to-shareholders-1017300757
You have the luck because this is likely the lowest price point this stock will track for years and years. tell a friend 10$
Effectively immediately, doctors in New Jersey can recommend their patients use medical marijuana to treat anxiety, various forms of chronic pain, migraines and Tourette's syndrome.
The conditions have been added under the first stage of a wide-ranging expansion of the medicinal marijuana program announced Tuesday by Gov. Phil Murphy. $evio
http://www.nj.com/marijuana/2018/03/chronic_pain_anxiety_migraine_sufferers_may_apply.html
$EVIO Labs Florida recently announced it would open a medical marijuana testing facility in Gainesville, the state’s first such facility north of Interstate 4. About a month ago, Toronto-based Liberty Health Sciences announced it will construct a facility to produce medical cannabis products and related items on a 387-acre site north of Gainesville.
http://www.gainesville.com/opinion/20180309/editorial-cheers-and-jeers
$EVIO Labs Florida recently announced it would open a medical marijuana testing facility in Gainesville, the state’s first such facility north of Interstate 4. About a month ago, Toronto-based Liberty Health Sciences announced it will construct a facility to produce medical cannabis products and related items on a 387-acre site north of Gainesville.
http://www.gainesville.com/opinion/20180309/editorial-cheers-and-jeers
Canada has a 5 Billion dollar cannabis industry in place and primed for launch this summer. There are a number of MASSIVE deals with cultivation facilities set up and fine tuning to ramp up industrial scale delivery which will require INDEPENDENT testing by CERTIFIED labs like $EVIO.
Canada is a jurisdiction in which HEMP has been cultivated commercially as a bulk agricultural product for sale in the form of oils, seeds, refined flour etc for close to 20 years. McConnell and his suite of talking heads can hint at opportunity and tease the pharma lobby positioning while spinning everyones wheels all they want.
$EVIO only needs to set up a shop north of the border and it instantly accesses another 10 Billion dollars in revenue pie to sit down and enjoy another almost monopoly providing a critically essential service to the fastest growing agricultural sector on Earth
Apparently the intern tasked with dumping shares at tangiers slept in this morning.
Checking CC CFO cv and he appeared to have been a stop gap to fill a need- was anticipating a more name brand long term hire more in the vein of what we’ve seen recently. Sector experienced large cap officers- something like a healthcare/ pharma experienced not only in the US but global. eVIO treasury right now can get them the best and heading up the financial side of an almost monopoly of an essential service in the fastest growing agricultural sector in the world is a pretty sweet gig that I think that the $EVIO board is going to have some of the sexiest CFO resumes in the world populating their inbox this week
Bids stacking - volume low - next logical step is? price jumps? its a slow starter some mornings though anything is possible
Canadian Cannabis Stocks Just Got a Little Less Risky:
https://www.fool.com/investing/2018/03/23/these-3-marijuana-stocks-arent-getting-any-respect.aspx
$EVIO provides state-of-the-art cannabis testing services nationwide, with eight operating laboratories in five states. The foundation of our coast-to-coast operation continues to be Oregon, the location of our prototype laboratories.
$EVIO services nearly thirty percent of the cannabis testing market in Oregon and continues to have some of the most stringent accreditation criteria in the nation.
Recent developments include the continued expansion of our testing capabilities, such as adding of delta-8 THC to our analyte list for cannabinoid profiling.
Pasadena Police Chief Resigns- Police Caught Selling High Powered Automatic Rifles to California Street Gangs -
I guess we now know why Pasadena city council has banned $EVIO and other cannabis deals from setting up shop in town. They didnt want any competition to their cozy Law Enforcement/ Street Gang narcotics cash cow.
#forthelittlekids #thoughtsandprayers
http://www.latimes.com/local/lanow/la-me-ln-pasadena-police-chief-retirement-20180312-story.html
Now, through testing subsidiary $EVIO Labs, the company plans to open 18 laboratories by the end of 2018 at locations throughout the United States.
The supply shortfall in California cannabis testing services is rising to crisis proportions at a time when one report warns that ‘much of the marijuana sold in dispensaries in California would fail safety standards in other states’
Quality issues plague the industry, as recent examples from further afield demonstrate. A couple of MMJ companies licensed under Canada’s ACMPR were found to be using banned pesticides, and a cancer patient died after acquiring a fungal contamination, which was said to have originated in smoked marijuana.
https://www.networknewswire.com/evio-inc-evio-sets-california-july-2018-mandatory-cannabis-testing-deadline-approaches/
the same thing posters have been saying for 18 months. Somehow someway on some magic date or with some magic event in the future ALL the problems in the world will be fixed and then EVERYONE will get "it" -all the phonys and passionless people- and they will come to their senses and magically the market will deliver value- sadly thats how it works in fairy tales but generally not how it works in the real world. the only way it does work is attention to detail, well thought out planning, smart execution and smarter work.
Tarballs are an aquatic pollutant- A tarball is a blob of petroleum which has been weathered after floating in the ocean.
yeah but he lost me when he used the third person reference. #hardno
Terry Booth is a director of Quinsam Capital: Who invested $450,000 into the last funding round:
https://www.bloomberg.com/research/stocks/people/person.asp?personId=281925946&privcapId=272485300
TORONTO, Jan. 29, 2018
Evio, Inc. (“Evio”): Quinsam expects to close today an investment of US$450,000 in units
of convertible debentures and warrants in the capital of Evio. The debentures convert at
US$0.60 and the warrants strike at US$0.80. The common shares are currently trading
at approximately US$2.15. Evio is an operator of cannabis testing labs in the United
States. We anticipate that Evio will pursue a Canadian listing.
http://www.quinsamcapital.com/pdf/Quinsam%20Capital%20Corporation%20Investments%20-final.pdf
Its like we get the regular "news bump" of volume and then once the diluters jump in. price drops. And because there has been no effective awareness campaign in place (2 years and running) there is no deluge of "new" investors who have bookmarked and are following the story etc. Rather its just dumping of paper as the price drops. Likely more regulars just picking up cheap paper. Leaving the holders thinking awesome. cheap paper!
But definitely not an environment the greater "market" wants to play in. That this stock isnt trading in a range of 2-3$ right now is criminal.
The fact that they chose their lead in tagline on their twitter/site to be: Passion Science Innovation - points to the crazy bad decisions in messaging.
Passion is fine, i guess, sure, internally communicated maybe? but you are an ANALYTICAL SCIENTIFIC TESTING COMPANY- CHEMISTS, SCIENTISTS perform critical laboratory tests to ensure the health and safety of a nation. And you want people to believe its your passion they should trust/rely on versus say SCIENCE!
First thing i look for in a doctor: forget their degree or specialties: do they have a passion for doctoring that surpasses every other doctor? The last five patients died on the operating table.... but you cant deny his/her passion passion for doctoring. Drilling down even further. What is EVIOs passion all about? Cannabis? Cannabis Testing? Life? Depressed share prices? Low Volume? Bad Messaging? Share Dilution? Who know? My guess is they couldnt even answer the question- it just feels good. Like a bunny that youre scratching behind the ears... it takes a few hops in the dreamland of your echo chamber... out into the real world whereupon an eagle swoops in and carries off the screaming bunny for dinner.
And book value has nothing to do with it. This is a small cap deal that has a potentially massive global upside. People will pay for that. Because no awareness campaigns are/ have been running to inform and hilight these critical points on a daily basis to the greater marketplace- doldrums are the result.
Again- forget book value. This isnt a fully matured blue chip billion dollar revenue deal with 100 quarters of performance. This is a small cap deal who have essentially cornered the marketplace of a mission critical specialty in the fastest growing agricultural sector on Earth.
The stock is worth whatever people will pay for it.
A pennant is a continuation pattern in technical analysis formed when there is a large movement in a stock, the flagpole, followed by a consolidation period with converging trendlines, the pennant, followed by a breakout movement in the same direction as the initial large movement, the second half of the flagpole.
The next $EVIO listings will come on Frankfurt Stock Exchange and all those rich smart German investors who get the cornering of the Cannabis Quality Control story, or: Canadas' CSE is obviously in play when $6,000,000 was just raised there last month. Once $EVIO is eligible for trading in Canadians beloved Tax Free Savings Accounts (TFSA)... wooo doggie- say hello to my friend 10$ a share!
The next step $EVIO makes after these two cross listings in Frankfurt & Toronto would be to the NYSE American (old-AMEX) skipping right over the QX - The QX is an exchange typically for ADR and mid-large cap foreign deals
$EVIO is currently qualified to list on the CSE in Canada and the FSE in Frankfurt - probably cost them $150,000 tops in apps and legal to be trading in both Canada & Germany inside 180 days.
Anticipate an $EVIO NYSE Americas uplist application anywhere from Sept 2018 - June 2019
Book it! lul -
$EVIO is not a penny stock - no matter how often you trash the deal - e
Buying $EVIO now is Like finding a Picasso at a garage sale.
Bargain Hunters looking for deals pre-Valentines WW $EVIO love note?
Scoreboard! Nice find!
Simply amazed. The sky is falling because of instant liquidation of paper from a raise. Now the sky is falling because they might not have the capacity? Whats next chicken little? Will their flux capacitor break?
Spoke & Hub and utilizing the transportation network i believe allows the company to move product around and utilize their facilities to max potential. Translation: $EVIO Lab in Bend for example say in one particular week has 12 clients a day walk in seeking pesticide testing for flower: Those samples are out by courier everyday to Portland to the pesticide testing facility. Conversely 24 clients a day in Portland are seeking thc/terpene profiles of flower - that can be couriered to any other lab in the group - Eugene or Medford to be done.
Point being: Each lab has its own size and capabilities and especially the flexibility option with the Spoke & Hub model and daily internal courier service. Your question is kind of unanswerable in a way... There arent 5 standalone $EVIO Labs operating in a vacuum in Oregon. By managing the work flow in a smart way they can get much more potential cash flow capacity out of each lab integrated than each lab standing alone.
The other thing to consider is that in principle they could handle as much lab work as anyone brings them. What would suffer in this scenario is turnaround time. So at one capacity they are delivering on average 48 hours turnaround and if they get "backed up" it can turn into 72 or 96.
Another point to consider when attempting to calculate lab work capacity is this: The labs are locked down from the admin office in each location. IT would not be very difficult to hire any number of scenarios. An overnight shift of lab techs - or a part time shift from 5pm - 9pm
Point being: Only start worrying about lab testing capacity once each lab is operating at 2 shifts per day -
THCM: Yes post away TOTHE: Yes, Sure thanks for thinking of me.
Ron Russak has been named vice president of operations at $Evio Inc., a life sciences company and provider of quality control testing and advisory services for the regulated cannabis industry.
Russak joins Evio from a 17-year career at Quest Diagnostics $DGX as regional director and 13 years at Pennsylvania Hospital — part of the University of Pennsylvania Health System — as administrative director of laboratory services. He has a bachelor’s degree in life sciences from the University of Pittsburgh and an MBA from La Salle University.
http://www.bendbulletin.com/business/5993577-151/business-people-on-the-move
Yes - Yuba - I had the same thoughts. What happened? Sooooooo. I did a little research and found this article by Joseph Ditzler in the Bend Bulletin business section - i read/browsed it at the time Jan 2, 2018....but obviously not closely enough because i missed this:
Right - you told me that before - Thanks! did you check out my FORECAST post #41619 - i came up with 1.286m but using the Oct 18 $EVIO PR came up with a number OVER 1.6m - and trending towards a 2.4m for the next quarter now that the pesticide testing is providing that 30-35% free money bump they were outsourcing.
that would be a Q1-Q2 $4,000,0000 - still a long way to 9.6m - but getting closer - Also - California: They currently have access to 2 Hub Labs Berkely/ Costa Mesa(Orange County) - Youd have to think that there will be a couple/ four spoke labs - without expensive pesticide equipment - to come in the next 45-180 days to support them.
And with California being 10x the Oregon market. Even a stumbling bureaucratic shitstorm of stumbles and clusterfucks for a month or three start will still deliver GARGANTUAN revs in comparison.
For example - if 4 slick fully running Oregon labs can deliver $30-40,000 a day in cash flow - Couldnt two hub labs and two spoke labs do that in California just falling out of bed?
And once the groove settles in say.... Sept - Dec 2018 that California could easily be generating $50,000 - $100,000 A DAY in revs?
Rumors that ive heard on the floors of a few cannabis conferences were that their Colorado Licensee - Phytatech dba/EVIO Colorado - is cashflowing $2,000,000 annually.
Take the EVIO PR projections, full Pesticides revs in Oregon and execute takeouts of options of Phytatech and C3 in Berkeley.... those two deals...
A little California love... i havent done the math but as im writing this - $9.4 might be way low - lets see
What happens to the stock if they come out with 1.5? is the market expectation overall 1.2m+-? Would 20% over expectations pop the stock? Would 30%?
Im thinking that whatever they come out with for the testing numbers for Q1 we could simply slap 30% on the NEW numbers and call it a forecast for Q2 - which if its $EVIO PR numbers....is close to $40,000 a day or $2,480,000 and pretty darn close to that 9.8m projection WW apparently dropped on a conference crowd speech in 2017
-btw i did use 13 weeks for the quarter - 65 business days = 13 x 5 minus 3 days for xmas thanksgiving and another day btwn xmas and NYE - used 62 potential cash flow days in the quarter as the basis -
I only wrote 12 weeks to get comments...LUL ;)~
Nope - just a shareholder with slight autistic tendencies - lul
$EVIO Q1 REVENUE FORECAST - Breakdown
Lets start with the quarter - Its 12 weeks long so, 65 business days. Remove the 2 holidays xmas and tgiving and another day for the lazy time between xmas and call it 62 business days of cash flow to calculate.
Last year $EVIO reported $568,000 in testing revenues (this breakdown will focus only on testing rev forecast because the consulting revenue, as anyone who has followed this deal seen in past Q's knows that consulting revs could be anywhere from $25,000 to $250,000 - Q1 2017 was $100,000- as far as im concerned $EVIO -for the moment- is a testing play and the consulting revenue is just free gravy) Back to it...
So: $568,000 testing revenue Q1 2017 - 4 Labs - 62 Days cashflow = $9161.29/day in $EVIO analytical testing cash flow.
But hold on.... We know -board regulars & $EVIO longs- that Oregons rollout launch of legal cannabis and especially testing was a bottleneck of clustercuss the first week of October 2016 so lets knock it down to... 59 days of cashflow. That kicks our daily number up to $9627/day cashflow
But wait. There's more: $EVIO Portland acquisition wasn't closed until Oct 22 - So lets call $EVIO #PDX cash flowing 52 days.
So: $EVIO Bend Eugene & Medford were cashflowing 59/62 potential days. Portland cash flowed only 52/62 days
Math part... if we use 62 as the potential days to cash flow in the Q and multiply that by 4 $EVIO Labs... that = 248 potential days. If everyone is comfortable with the PDX Lab 52/62 and the other 3 at 59.... We come up with a number of 229 days of cash flow that $EVIO was actually operating out of the 248 days they could have potentially cash flowed. make sense?
Take the 229 days and divide by 4 Labs (to all the math pros and stats peeps...i know this is very rough and not likely the best way to get at this - but im trying to get a number within like $1-200,000+- not 1 or 2 dollars)
When we divide the number of actual days that each lab was actually cash flow Q1 2017 by the number of labs operating for these days...we get 229/4= 57.25 - lets call it 57 for ease of math - which we could argue, for this very back of napkin formula - means that $EVIO Labs $586,000 Q1 2017 testing revenue $586,000/57= $10,280/day cash flow (on average) per lab per open business day.
So: if everything was in stasis and there was no growth or operational efficiency improvements etc that Q1 2018 $EVIO is 62 days open x $10,280 = $637,000 in Q1 testing cash flow.
$637,000 would be a huge disappointment, right? No worries though. We can definitely anticipate that everything is smooth flow form and most all the growing pains associated with the legalization launch in Oregon, staffing, maintenance, device calibration, deliveries, pickups, turnaround times are behind them.
There is also edibles testing to consider. Last year saw an explosion in companies providing cannabis edibles in almost every possible concoction that your imagination could ever dream of.
This is important to know because the testing of edibles is a HUGE challenge due to the HUGE variety of substrates that companies use. Gummies, gum, candy, drinks crackers, licorice - all of the cane sugars, raw sugar, stevia, fructose, corn syrup, chocolate etc etc never mind additives, fillers, binders raise HOLY HELL with the scientists ingenuity, creativity and scientific ingenuity and sensitive equipment used in these labs- another doozy is that that a processor wont be fully transparent with the labs about the ingredients for the sake of IP protection. Only for the reason that hardly anybody, anywhere is doing these tests this way in the food, agricultural pharma sectors.
Typically an analytical testing lab testing beef or apples or cannabis flower is testing those items. For example - Beef is tested before it is sold to a restaurant but nobody is testing it after it is cooked and covered in juice and sauce and mushrooms. OR Apples might be tested from the orchard as a batch. But nobody is requiring that a candied apple on a stick needs to be analytically tested. Cannabis flower is easy enough. Blender, alcohol, draw a sample.
-off on a tangent - back to the Forecast
Point being - $EVIO Labs Portland is (reportedly) the ONLY analytical testing lab in the Portland area that will even PERFORM edibles testing.
So all that being said - growing pains, operational improvements, marketing, edibles - I am going to slap a 40% revenue increase for these points - old number was $637,000 x 1.4 = $891,000 - still not impressed - neither am i...
Lets drill down - Nov 22 2017 saw EVIO PR the approval of their pesticide testing license - until that point the company had to outsource ALL of their required pesticide testing. We are going to use a number of 35% increase to the revenues by keeping that inhouse.
So: if we go with the $891,000 base of lab testing revs divided by - 62 days of cash flow - $14,383/day - We know the PR was issued on Nov 22 - Thansgiving/Xmas included lest call it 24 cash flow days in the Q -
Take $14,383 x 1.35 = $19,418 cash flow per business day from Nov 22 - Jan 31
Now we have:
38 days x $14,383 = $546,554
24 days x $19,418 = $466,032
Total: $1,012,586 - Oregon Testing revenue
$EVIO Eastern Oregon/ California/ Colorado- Licensee/ Mass- Licensee /Florida- Licensee
Lets call that $200,000
Throw in $75,000 for consulting
Forecast Q1 2017 $EVIO Total revs - $1,287,000
imho - 10% higher than that - $1.388m would pretty exciting and anything over $1,450,000 should see the market respond strongly.
Which brings me all the way around back to an $EVIO PR from Oct 18, 2017 where the company said:
October had 22 business days in 2017 - Starting on Mon Oct 2 - if we were to extrapolate that (surpassing) $250,000 and call half the month 11 days as per $EVIO PR - $250,000/11 = $22,727/day cashflow!
$22,727 is SIGNIFICANTLY higher than the $14,383 that i had guestimated up a paragraph or two ago, right?
We take the same calculation as used above from MY forecast and insert $EVIO PR numbers, it gets crazy...
38 days x $22,727 = $863,636 - outsource pesticide testing
24 days x $30,681 = $736,344 - in-house pesticide testing
= $1,599,707 Projected Q1 2017 $EVIO Testing Revs
For arguments sake lets assume $EVIO Oct 2018 PR included California/ assorted licensees in the mix - and add $75,000 in consulting revenue.
Thats $1,674,000 in Forecast Q1 2017 $EVIO revs - using $EVIO PR #'s - 243% YOY INCREASE
and $1,262,000 using my napkin method. 185% YOY increase
What do you guys think? of the forecast? of market reaction to either of these numbers?
thanks for reading if you made it this far...
lawyer lawyers lawyers... dont listen to me im just an idiot on the internet. do your research and DD and draw your own conclusions.
Calm before we storm the wall over $2 - $2.50 - 3$? next weeks financials drop yo - btw any guesses on Q1 revs on the board? ive got mine broken down in pathetic detail... posting shortly for your enjoyment. or better to ignore it maybe. #beauregard
IKR - Is this the Onion you wonder....Nope! Sessions went on to say that while the Drug Enforcement Agency may think that “a huge percentage of heroin addictions start with prescriptions,” he thinks there’s another cause. “We think a lot of this is starting with marijuana..."
MEANWHILE...yesterday! the RAND Corp releases a federally funded study!
https://www.rand.org/news/press/2018/02/06.html
$EVIO have plans for the $6,000,000 raise and a lean might be its going to happen fast. Take out a note or two. Exercise an option on a currently licensed $EVIO Lab in Berkeley, Denver, Florida or near Boston? Maybe a lab acquisition in a a place never mentioned before? Nevada - Canada - Europe? Rockstar board appointment? Rockstar IR team hire? Another California Lab?
They have a nice chunk in the treasury and have had plenty of time to plan how they are going to allocate it....
Remeber that four of their five $EVIO Labs are ORELAP certified (ISO-17025 equivalent) and now after the licensing agreement is in place their licensees in Florida and now Colorado are both ISO-17025 certified.
Thats SIX ISO-17025 Labs! SIX!
I dont believe now there is a group on Earth who has as much institutional and operational expertise in professional Analytical Laboratory Cannabis Testing Science as $EVIO
Its the largest Cannabis Quality Control provider of a state mandated service in the fastest growing agricultural sector on Earth. ANd we havent even explored the Bio-Tech opportunities resulting from the IP of 75,000 tests in the past 3 years. Terpenes, Cannabidinol, Hemp -Take your time making a share purchase. It def needs more marination
There is a contingent on the board leftover from the pink sheet status of the deal, its not their fault they are so special... the penny market experience has left them maybe?.... bitter and jaded and suspect that every deal is a set up, a scam, a dump, manipulated, etc.they have yet to cotton on to the new $EVIO CASH reality and are stuck in time like extinct bugs in amber.
Its the meme of #TestingCannabis overall i think. Wherever there is/ will be a legal marketplace of cannabis for sale anywhere in the country or the World tbh. EVIO Labs has another cash flow opportunity.